Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription

The portion meant for qualified institutional buyers (QIBs) was subscribed 50 per cent, while the non-institutional investors’ category received 1.14 times subscription and those for retail individual investors (RIIs) 8.24 times, according to an update on NSE.

Original source: https://health.economictimes.indiatimes.com/news/pharma/84495067?utm_source=RSS&utm_medium=ETRSS

Related Posts